November 14, 2024CorporateTerumo Blood and Cell Technologies Unlocks New Chapter of Localization in China to Facilitate Blood and Cell Treatment Options for Patients
November 12, 2024CorporateTerumo Blood and Cell Technologies Merges Therapeutics Units to Enhance Patient Care Across Treatment JourneyNew Global Therapy Innovations business unit, led by Veerle d’Haenens, aims to unify therapeutic apheresis and cell and gene therapy expertise to expand therapeutic possibilities
November 07, 2024FinancialNotice Concerning Revisions to Full-Year Consolidated Financial Guidance for Fiscal Year Ending March 31, 2025 (FY2024) (PDF 85.27 KB)
FYE 3/2024 FYE 3/2023 FYE 3/2022 FYE 3/2020 FYE 3/2019 FYE 3/2018 FYE 3/2017 FYE 3/2024 Consolidated Financial Statements (PDF 1.11 MB) FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB) FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB) FYE 3/2020 Consolidated Financial Statements (PDF 1.48 MB) FYE 3/2019 Consolidated Financial Statements (PDF 1.52 MB) FYE 3/2018 Consolidated Financial Statements (PDF 1.77 MB) FYE 3/2017 Consolidated Financial Statements (PDF 2.93 MB) Adobe Reader (free) is required to view PDF files. Download Adobe Reader
FYE 3/2023 Consolidated Financial Statements (PDF 1.31 MB) Consolidated Financial Statements (PDF 1.31 MB)
FYE 3/2022 Consolidated Financial Statements (PDF 1.19 MB) Consolidated Financial Statements (PDF 1.19 MB)
Top
Top